Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rang in Aktien #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aktienkurs
$0.0202
Zuletzt synchronisiert: 2024-11-19
Marktkapitalisierung
$44.67K
Veränderung (1 Tag)
-0.49%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Kategorie

Aktien-Split-Historie für Notable Labs, Ltd. (NTBL)
Die Aktie Notable Labs, Ltd. (Symbol: NTBL) durchlief insgesamt 1 Aktiensplits.
Der letzte Aktiensplit fand am Oct 17, 2023 statt.
Eine NTBL-Aktie, die vor dem Oct 17, 2023 gekauft wurde, entspricht heute 0.028571428571429 NTBL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2023-10-17 1:35 x0.028571428571429 x0.028571428571429
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE